Mr. Wee was appointed to the Board as an Independent Non-Executive Director of the Company on 1 February 2022.

A faculty member and fellow of the Institute of Corporate Directors Malaysia, he is also managing partner of CG Board Asia Pacific Sdn Bhd, a provider of learning and leadership development in governance, risk management and internal control, since 2005.

He has worked in a number of multinational companies as Chief Audit Executive, his last position being with AstraZeneca (UK) as the Regional Audit Director of Asia Pacific, Middle East and Africa. Mr. Wee was an independent director of three public listed companies, two in the ACE Market of Bursa Malaysia and one in AIM of the London Stock Exchange.

Mr. Wee was the recipient of the Malaysian Internal Auditor of the Year Award in 2001. He holds a Certification in Risk Management Assurance from the US, and is a Chartered Fellow of IIAM, a Chartered Accountant (M) with Malaysian Institute of Accountants as well as a Fellow of the Association of Chartered Certified Accountants (UK).